The purpose of the report is to illustrate the state of the market of Polyphthalamide, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.
Browse here for full report with Toc: https://www.credenceresearch.com/report/polypthalamide-market
The global polyphthalamide (PPA) market is projected to experience significant growth over the forecast period due to increasing demand for light weight automotive components. Rise in demand from electronics and electrical segment is another factor contributing towards market growth. Polyphthalamide is very resistant to chemicals and exhibits minimum changes in physical properties after moisture uptake; this is very vital in electrical and electronics fields when components undergo lead-free reflow soldering and functional parts must have extremely good dimensional stability. These include connectors, micro switches and micro sensors, and even semi-conductor components such as the reflector housings of light-emitting diodes (LED).
Some of the key players present in this market are EMS Chemie Holding AG, Solvay S.A., DUPONT EI DE Nemours & Co., Arkema S.A., Evonik Industries AG and SABIC among others.
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Polyphthalamide buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Polyphthalamide contains:
Analysis and forecast of Polyphthalamide market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Polyphthalamide market;
Assessment and forecast of Polyphthalamide market development;
Financial and business profiles of the leading companies in the Polyphthalamide industry.
Also you can request us for sample in PDF with depth details and graph: https://www.credenceresearch.com/sample-request/57761
– Up to date working Polyphthalamide data by major regions in the world, the forecast of planned capacity additions by 2026
– The annual breakdown of capital expenditure spending on proposed Polyphthalamide for the period 2018 to 2026
– Planned Polyphthalamide additions and capital expenditure spending by key countries and companies across the world
– Planned capital expenditure spending on new Polyphthalamide projects by region, key countries, and companies
– Details of major planned Polyphthalamide projects in the world up to 2026
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Credence Research Inc.
105 N 1st ST #429
Toll Free (US/CANADA): +1-800-361-8290